Back to Search
THEODORE JOHNSON, M.D.
M.D.
General Practice Physician
NPI: 1528300191Individual
Specialties, Licenses & Credentials
Research & Publications (20)
TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity.
PMID 19428918·Vaccine·2009
7-preclinical
Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein.
PMID 18519743·J Leukoc Biol·2008
7-preclinical
Water balance and cation levels in Drosophila: can early physiological decline predict aging and longevity?
PMID 16510858·J Gerontol A Biol Sci Med Sci·2006
7-preclinical
Bovine polymerized hemoglobin (hemoglobin-based oxygen carrier-201) resuscitation in three swine models of hemorrhagic shock with militarily relevant delayed evacuation--effects on histopathology and organ function.
PMID 16540964·Crit Care Med·2006
4-observational
Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
PMID 14730270·Pediatr Infect Dis J·2004
4-observational
IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.
PMID 12574374·J Immunol·2003
7-preclinical
After repair, atrioventricular valve regurgitation during cardiac extracorporeal membrane oxygenation predicts survival.
PMID 12963214·Ann Thorac Surg·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 141 S MOUNTAIN DR
NEW BRITAIN, CT 06052 - Phone
- (860) 223-3435
Quick Facts
- NPI
- 1528300191
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile